nan

Medtech Companies Gained 45.6% in FY15, And A Strong FY16 Expected

Canaccord Genuity
Canaccord Genuity
Stockbroker

Ground-breaking study may lead to accelerated sales pipeline for Nanosonics

Canaccord Genuity
Canaccord Genuity
Stockbroker